Orbray Co., Ltd.
USPTO PatentsView assignee record - 8 granted patents across 11 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G02B (Optical Elements, Systems OR Apparatus).
The verdict
According to USPTO PatentsView, Orbray ranks #32,765 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 11 technology areas.
- #32,765
- of 49,997 US assignees by volume
- Top 29%
- by Innovation Score (43.1/100)
- 6.4
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R32765 · Foreign Corporation #32,765 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-SPARSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 8 grants
- MID-PACK #32,765/49,997
- PHOTO-FINISH Optimus Drugs Private
- CPC-FOCUS G02B · 11 areas
- INNOV-PAR 43.1/100
- CLAIMS-SPARSE 6.4 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2023–2025 · 3y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Optimus Drugs Private Limited (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Orbray’s 43.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Orbray
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Orbray · this assignee
Orbray · this assignee
43 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Orbray's Innovation Score is 43.1/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Orbray?
Each dot is one of Orbray’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Orbray’s own 6.4 claims/patent is at or below the 15.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Orbray's grants concentrate
Orbray Co., Ltd. is a focused PatentsView assignee: 11 CPC subclasses with 37.5% of grants classified under G02B (Optical Elements, Systems OR Apparatus). Peak complete grant year is 2024 (5 grants) versus a trough of 1 in 2023. By volume, Orbray sits between Optimus Drugs Private Limited and Orth Consulting, LLC.
Orbray's three-year grant acceleration
Orbray Co., Ltd. shows 6 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Orbray's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Optimus Drugs Pri…
Optimus Drugs Private Limited
8 patents
- Optivolt Labs
Optivolt Labs, Inc.
8 patents
- Optofluidics
Optofluidics Inc.
8 patents
- Orbital Composites
Orbital Composites, Inc.
8 patents
- Orchid Exchange
Orchid Exchange Inc.
8 patents
- Orexigen Therapeu…
Orexigen Therapeutics, Inc.
8 patents
- Orgenesis
Orgenesis Inc.
8 patents
- Orth Consulting
Orth Consulting, LLC
8 patents
- Orbray ◀
Orbray Co., Ltd.
8 patents
What this shows Orbray holds 8 patents at rank #32,759, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Orbray
By rank, the assignees closest to #32,759 in granted patent volume.
- Optimus Drugs Private Limited #32,755 · 8 patents
- Optivolt Labs, Inc. #32,756 · 8 patents
- Optofluidics Inc. #32,757 · 8 patents
- Orbital Composites, Inc. #32,758 · 8 patents
- Orchid Exchange Inc. #32,760 · 8 patents
- Orexigen Therapeutics, Inc. #32,761 · 8 patents
- Orgenesis Inc. #32,762 · 8 patents
- Orth Consulting, LLC #32,763 · 8 patents
Leaders in G02B (Optical Elements)
Other assignees with the most granted patents in Orbray's primary technology class.
- Samsung Electronics Co., Ltd. 4,608 in class
- Canon Kabushiki Kaisha 2,525 in class
- Fujifilm Corporation 2,173 in class
- BOE Technology Group Co., Ltd. 1,899 in class
- Olympus Corporation 1,893 in class
- Sony Group Corporation 1,572 in class
- Apple Inc. 1,367 in class
- Seiko Epson Corporation 1,332 in class
Orbray's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
43 Top 29% higher than 71% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 1 | 12.5% |
| 2024 | 5 | 62.5% |
| 2025partial year | 2 | 25.0% |
Which technologies does Orbray Co., Ltd. patent most?
Top 11 of 11 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Orbray Co., Ltd.'s patent record in context - here's where to go next.
- Orbray Co., Ltd.'s lead technology class is G02B (Optical Elements, Systems OR Apparatus), 37.5% of its portfolio - see every assignee active in that class. Explore G02B
- Ranked #32,765 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Orbray Co., Ltd. against Optimus Drugs Private Limited, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 43.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.